NCT00293917已完成3 期
A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 658
- 试验地点
- 37
- 主要终点
- Safety
研究概览
简要总结
A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis
详细描述
A long-term, open label, non-comparative, multi-center study to evaluate the safety of tacrolimus cream-B 0.1% in treating the signs and symptoms of psoriasis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of plaque psoriasis
排除标准
- •Skin disorder other than plaque psoriasis in the areas to be treated.
- •Disease on only scalp
结局指标
主要结局
Safety
时间窗: 12 months
次要结局
- Efficacy(12 months)
研究者
研究点 (37)
Loading locations...
相似试验
已完成
3 期
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisPsoriasisNCT00293930Astellas Pharma Inc645
已完成
3 期
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisPsoriasisNCT00293891Astellas Pharma Inc658
进行中（未招募）
2 期
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque PsoriasisPlaque PsoriasisNCT05739435Alumis Inc165
已完成
4 期
Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for MelasmaMelasmaNCT00472966Galderma R&D20
已完成
2 期
Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisDermatitis, AtopicNCT00560326Astellas Pharma Inc50